- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Plane joint.
Displaying page 1 of 1.
EudraCT Number: 2018-000089-12 | Sponsor Protocol Number: HIP/FUSION#4 | Start Date*: 2018-04-24 | |||||||||||
Sponsor Name:Institut for Klinisk Medicin, Aarhus Universitet | |||||||||||||
Full Title: Effect and safety of the iliopsoas plane block in healthy volunteers | |||||||||||||
Medical condition: No specific medical condition is investigated. The objective of the trial is to investigate a method for postoperative analgesia after elective hip surgery. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-005838-15 | Sponsor Protocol Number: 01-10122020 | Start Date*: 2021-03-22 | |||||||||||
Sponsor Name:Aarhus University Hospiotal | |||||||||||||
Full Title: The effect of iliopsoas plane block on opioid consumption and pain after hip arthroscopy A double-blind randomized, controlled trial | |||||||||||||
Medical condition: Postoperative pain after hip arthroscopy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005775-16 | Sponsor Protocol Number: SUBLIME1 | Start Date*: 2012-06-19 | |||||||||||
Sponsor Name:Research and Development Department | |||||||||||||
Full Title: A randomised, double blind, placebo-controlled trial of continuous subpectoral local anaesthetic infusion for pain and shoulder function following mastectomy. | |||||||||||||
Medical condition: Post-operative pain following mastectomy surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001409-26 | Sponsor Protocol Number: OMS-I103 | Start Date*: 2020-02-10 | ||||||||||||||||
Sponsor Name:OncoSec Medical Incorporated | ||||||||||||||||||
Full Title: A Multicenter Phase 2, Open-Label Study of Intratumoral Tavokinogene Telseplasmid (tavo, pIL-12) plus Electroporation in Combination with Intravenous Pembrolizumab in Patients with Stage III/IV Mel... | ||||||||||||||||||
Medical condition: Stage III/IV Melanoma | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: PL (Completed) IT (Completed) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
